Chris was appointed Senior Vice President of Business Development of INVO Bioscience in February 2021 after beginning with INVO as Vice President of Business Development in April 2020.
He has a broad cross-section of experience in the medical device industry spanning more than 20 years. Prior to joining INVO Bioscience, Chris served for four years in the Fertility and Genomics Group at CooperSurgical, Inc., a leading women’s healthcare provider. Most recently, Chris was Director of Corporate Accounts and Strategic Relationships for North America and was previously Regional Sales Director of the Fertility & Genomics Business Unit in the mid-Atlantic and Southeast regions of the U.S. Chris also worked at leading medical device and capital equipment companies including Alliance Healthcare and McKesson Corporation. Chris holds a BS degree from Southern Connecticut University and an MBA from Southern New Hampshire University.